Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

Status:
Completed

Trial end date:
2014-04-01

Target enrollment:

Participant gender:

This study will evaluate the preliminary safety and efficacy of PDS 1.0 in patients with neovascular AMD.

Phase 1

Forsight Vision4